Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease

Converging evidence from genetic, pathological and experimental studies have increasingly suggested an important role for autophagy impairment in Parkinson’s Disease (PD). Genetic studies have identified mutations in genes encoding for components of the autophagy-lysosomal pathway (ALP), including g...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Molecular neurodegeneration Ročník 12; číslo 1; s. 11
Hlavní autori:	Moors, Tim E., Hoozemans, Jeroen J. M., Ingrassia, Angela, Beccari, Tommaso, Parnetti, Lucilla, Chartier-Harlin, Marie-Christine, van de Berg, Wilma D. J.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London BioMed Central 25.01.2017 BioMed Central Ltd Springer Nature B.V
Predmet:	Autophagy (Cytology) Biomedical and Life Sciences Biomedicine Care and treatment Dosage and administration Genetic aspects Health aspects Life Sciences Molecular Medicine Neurology Neurosciences Parkinson's disease Rapamycin Review Risk factors Autophagic Cell Death Dementia With Lewy Body Ambroxol Dementia With Lewy Body Patient Gauche Disease
ISSN:	1750-1326, 1750-1326
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!